PMID: 42305307

A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study.

Wang Yu-Zhen, Hu Qing-Qing, Xu Lu-Yao, Li Liu-Cheng, Xu Jun-Jie, Mao Kai-Li

Archives of medical science : AMS · 2026

Vol. 22, Issue 2, pp. 1224-1233

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.